- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Gemcitabine, Bosutinib
Total 3133 results
-
PfizerCompleted
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
PfizerCompletedHealthy ParticipantsNetherlands
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedHealthyUnited States
-
Kyoto UniversityPfizer; Kitasato University; Tokushima University; Tottori UniversityRecruiting
-
PfizerCompleted
-
Children's Oncology GroupPfizer; Erasmus Medical Center; Dutch Childhood Oncology Group; Innovative Therapies...Active, not recruitingAccelerated Phase Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Blastic Phase Chronic Myelogenous Leukemia | Philadelphia Chromosome Positive CMLUnited States
-
PfizerCompletedRenal Insufficiency, Chronic | Renal Insufficiency, Acute | Renal Disease, End-StageUnited States
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Canada, Spain, China, Australia, Singapore, Korea, Republic of, France, Hong Kong, Netherlands, Turkey, Poland, Japan, United Kingdom, Argentina, Colombia, Hungary, Russian Federation, South Africa, Belgium, Brazil, Chil... and more
-
PfizerCompletedLeukemia, Chronic MyelogenousJapan
-
PfizerCompletedMyeloid LeukemiaUnited Kingdom
-
PfizerCompleted
-
PfizerpH AssociatesCompletedChronic Myeloid LeukaemiaUnited Kingdom
-
PfizerCompletedPolycystic Kidney, Autosomal DominantUnited States, Canada, Australia, Sweden, Spain, Poland, Korea, Republic of, Switzerland, United Kingdom, Moldova, Republic of, Italy, Czech Republic, Hungary, Lithuania, Romania, Slovakia, Turkey
-
Massachusetts General HospitalPfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompleted
-
PETHEMA FoundationCompleted
-
Georgetown UniversityAlzheimer's AssociationCompletedDementia With Lewy BodiesUnited States
-
PfizerCompletedBreast Neoplasms | Neoplasm MetastasisUnited States, Ukraine, Russian Federation, Hong Kong, France, Australia, Poland, Malta
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedBreast Cancer | Leukemia, Myeloid, ChronicPoland
-
University of California, San FranciscoUniversity of UtahTerminatedPancreatic CancerUnited States
-
PfizerCompletedPhiladelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML)Singapore
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruiting
-
University of BonnPfizer; RWTH Aachen University; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsUnknownChronic Myelogenous LeukaemiaGermany
-
PfizerDevelopmental Therapeutics ConsortiumTerminatedPreviously Treated PH + CMLSpain, United States, Austria, Sweden, Germany, France, Italy, Norway
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Neurological Associates of West Los AngelesPfizerEnrolling by invitationDementia | Mild Cognitive ImpairmentUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); PfizerTerminatedChronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts Under 15 Percent of Bone Marrow Nucleated Cells | Blasts Under 15 Percent of Peripheral Blood White Cells | Blasts Under 30 Percent of Bone Marrow Nucleated Cells | Blasts Under 30 Percent of Peripheral Blood White CellsUnited States
-
PfizerCompletedChronic Myeloid LeukemiaUnited States, Spain, Australia, Canada, Hong Kong, Singapore, United Kingdom, Germany, Netherlands, Chile, India, South Africa, Sweden, Peru, Argentina, Italy, Austria, Colombia, Brazil, China, Finland, Hungary, Korea, Republic of, M... and more
-
PfizerCompletedChronic Myelogenous LeukemiaJapan
-
Beijing Pearl Biotechnology Limited Liability CompanyCompleted
-
Beijing Pearl Biotechnology Limited Liability CompanyCompletedNon-Small Cell Lung CancerChina
-
University of Milano BicoccaIRCCS San RaffaeleCompletedLeukemia | BCR-ABL Positive | Myelogenous | ChronicItaly
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedLeukemia | Breast Cancer | TumorsNetherlands
-
Beijing Pearl Biotechnology Limited Liability CompanyRecruitingNon-small Cell Lung CancerChina
-
Fundacion Espanola para la Curacion de la Leucemia...Pfizer; Roche Farma, S.ATerminatedChronic Phase-Chronic Myeloid LeukemiaSpain
-
St. Olavs HospitalOdense University Hospital; Oslo University Hospital; University Hospital of... and other collaboratorsRecruitingChronic Myeloid LeukemiaNorway, Denmark, Finland, Sweden
-
PfizerCompletedHealthyUnited States
-
Astellas Pharma Global Development, Inc.Basilea Pharmaceutica International LtdCompletedHealthy Volunteers | Pharmacokinetics of Isavuconazole | Renal ImpairedUnited States
-
Avistone Biotechnology Co., Ltd.RecruitingNon-Small-Cell Lung CancerChina
-
PfizerTerminatedAdvanced Breast Cancer (Parts 1 and 2) | Advanced Pancreatic Cancer (Part 1) | Advanced Colorectal Cancer (Part 1) | Advanced Cholangiocarcinoma (Part 1) | Advanced Glioblastoma Multiforme (Part 1)United States, Spain, Hong Kong, Belgium, Australia, France
-
Baylor College of MedicineRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission | Chronic Myeloid Leukemia in RemissionUnited States
-
Universitätsklinikum Hamburg-EppendorfHannover Medical School; Ludwig-Maximilians - University of Munich; Heidelberg... and other collaboratorsTerminated
-
Mohammed MilhemUniversity of Iowa; Holden Comprehensive Cancer CenterCompletedSarcoma | Pancreatic Ductal AdenocarcinomaUnited States
-
Gyeongsang National University HospitalSamsung Medical Center; Dong-A University; Chung-Ang UniversityTerminatedMetastatic Biliary Tract Cancer | Locally Advanced Biliary Tract CancerKorea, Republic of
-
BeiGeneActive, not recruitingRecurrent or Metastatic Nasopharyngeal CancerChina, Taiwan, Thailand
-
PfizerCompletedLeukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) PositiveFrance, United States, Canada, Spain, Czechia, Singapore, Thailand, Denmark, Norway, Korea, Republic of, Finland, Hungary, Sweden, Netherlands, Italy, Germany, Ukraine, South Africa, Taiwan, Australia, Belgium, Israel, Mexico, Poland, S... and more